Pulmuone Corporate

KOSE:A017810 Stock Report

Market Cap: ₩406.2b

Pulmuone Past Earnings Performance

Past criteria checks 1/6

Pulmuone's earnings have been declining at an average annual rate of -33.8%, while the Food industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 6.9% per year. Pulmuone's return on equity is 4.3%, and it has net margins of 0.4%.

Key information

-33.8%

Earnings growth rate

-33.6%

EPS growth rate

Food Industry Growth10.5%
Revenue growth rate6.9%
Return on equity4.3%
Net Margin0.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Mar 27
We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Recent updates

At ₩11,410, Is Pulmuone Corporate (KRX:017810) Worth Looking At Closely?

Nov 15
At ₩11,410, Is Pulmuone Corporate (KRX:017810) Worth Looking At Closely?

Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Jul 26
Pulmuone (KRX:017810) Use Of Debt Could Be Considered Risky

Pulmuone's (KRX:017810) Returns Have Hit A Wall

Jun 12
Pulmuone's (KRX:017810) Returns Have Hit A Wall

Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

May 24
Pulmuone Corporate (KRX:017810) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

May 24
Market Participants Recognise Pulmuone Corporate's (KRX:017810) Revenues Pushing Shares 31% Higher

We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Mar 27
We Think Pulmuone's (KRX:017810) Profit Is Only A Baseline For What They Can Achieve

Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

Apr 13
Is Now An Opportune Moment To Examine Pulmuone Co., Ltd. (KRX:017810)?

There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Mar 26
There Are Reasons To Feel Uneasy About Pulmuone's (KRX:017810) Returns On Capital

Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Mar 08
Pulmuone Co., Ltd. (KRX:017810) Is Yielding 0.6% - But Is It A Buy?

Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Feb 18
Here's Why Pulmuone (KRX:017810) Has A Meaningful Debt Burden

Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Jan 31
Does Pulmuone's (KRX:017810) Share Price Gain of 57% Match Its Business Performance?

Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

Jan 13
Based On Its ROE, Is Pulmuone Co., Ltd. (KRX:017810) A High Quality Stock?

When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Dec 26
When Should You Buy Pulmuone Co., Ltd. (KRX:017810)?

Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

Dec 08
Key Things To Watch Out For If You Are After Pulmuone Co., Ltd.'s (KRX:017810) 0.6% Dividend

These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Nov 20
These 4 Measures Indicate That Pulmuone (KRX:017810) Is Using Debt Extensively

Revenue & Expenses Breakdown

How Pulmuone makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSE:A017810 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,157,98412,858653,48230,148
30 Jun 243,070,3858,543646,68730,032
31 Mar 243,032,7228,857642,18929,498
31 Dec 232,993,4689,365635,03929,646
30 Sep 232,958,921-36,229634,82728,345
30 Jun 232,967,237-32,783631,74328,180
31 Mar 232,917,752-29,683620,98727,785
31 Dec 222,838,304-29,957612,20327,630
30 Sep 222,752,559-1,547593,58928,169
30 Jun 222,659,691-786582,74728,130
31 Mar 222,588,871-3,820573,75627,135
31 Dec 212,518,8965,326557,09928,289
30 Sep 212,457,29312,577544,85425,909
30 Jun 212,399,10812,989533,29827,111
31 Mar 212,329,17517,542514,64329,329
31 Dec 202,311,20014,880514,15529,245
30 Sep 202,339,35315,663519,52831,716
30 Jun 202,362,83913,047519,96030,289
31 Mar 202,394,78015,121521,80728,588
31 Dec 192,381,4512,092515,59326,789
30 Sep 192,341,49912,708502,18025,290
30 Jun 192,300,88215,531488,61924,692
31 Mar 192,276,08515,987485,85524,032
31 Dec 182,271,97320,448486,41923,452
30 Sep 182,257,20924,953480,08522,926
30 Jun 182,244,98629,473479,15722,191
31 Mar 182,222,75035,628468,65421,562
31 Dec 172,195,65838,506456,66620,862
30 Sep 172,182,18242,149464,53721,487
30 Jun 172,134,20636,862473,30620,339
31 Mar 172,089,07820,413476,14220,064
31 Dec 162,030,67318,595476,08119,937
30 Sep 161,963,63820,184457,65118,354
30 Jun 161,917,45112,666444,23218,979
31 Mar 161,874,81319,773427,83718,798
31 Dec 151,846,48820,319424,66218,314
30 Sep 151,822,00458,819402,72217,976
30 Jun 151,789,62760,187398,55417,536
31 Mar 151,743,29057,841397,02916,903
31 Dec 141,678,09455,023379,33616,665
30 Sep 141,615,684-5,251388,50716,066
30 Jun 141,565,074-3,726370,59315,627
31 Mar 141,538,641-6,555356,45515,287
31 Dec 131,521,708-6,299351,36814,736

Quality Earnings: A017810 has a large one-off loss of ₩7.5B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: A017810 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A017810's earnings have declined by 33.8% per year over the past 5 years.

Accelerating Growth: A017810 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A017810 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Food industry (3.8%).

Return on Equity

High ROE: A017810's Return on Equity (4.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:27
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pulmuone Corporate is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yu-jung HanDaishin Securities Co. Ltd.
So Min OhEugene Investment & Securities Co Ltd.
Ju Lee SohnKB Investment & Securities Co., Ltd.